Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin in Carcinoma of the Esophagus and Gastric Cardia

NCT00004127 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00004127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin in Carcinoma of the Esophagus and Gastric Cardia
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2000
Completion date
August 31, 2003
Enrollment
35 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, gastric cancer